The FDA has granted approval for a new over-the-counter medication that combines the active ingredients in Tylenol and Aleve. This product, known as Tylenol with Naproxen, marks the first time these two common pain relief components are available in a single fixed-dose pill.
Kenvue, the parent company behind Tylenol, reports that the new medication starts working within 30 minutes. The drug provides up to 12 hours of pain relief for adults and children 12 years and older. According to clinical studies, the combination performs more effectively than either acetaminophen or naproxen sodium when used individually.
This approval is tied to current federal health initiatives aimed at increasing access to reliable over-the-counter treatments. By consolidating these two ingredients, the manufacturer seeks to help patients avoid the common trial-and-error approach to managing minor aches and pains. This medication is designed to treat various conditions including headaches, muscle aches, backaches, toothaches, menstrual cramps, and minor arthritis pain.
Kenvue has secured three years of market exclusivity for this specific formulation. The company expects the product to hit store shelves soon, providing consumers with a non-opioid option for longer-lasting pain management.